Patents by Inventor Sascha Tillmanns

Sascha Tillmanns has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for treating an inflammatory disease and/or an autoimmune disease with a soluble Fc?RIIb
    Patent number: 10028998
    Abstract: The present invention relates to a method for treating or preventing either one or both of an inflammatory disease and an autoimmune disease in a patient, wherein the method comprises providing a pharmaceutical composition containing a therapeutically effective amount of soluble Fc?R; administering said composition to a patient, followed by a safety period of several weeks, followed by a subsequent treatment cycle of at least two weekly administrations, wherein said therapeutically effective amount is effective to treat or prevent said disease in said patient. The present invention also provides a pharmaceutical composition in the form of a multiple-dosage-kit which contains sufficient amounts of administration doses of soluble Fc?R for effectively treating or preventing inflammatory diseases and/or autoimmune diseases in a patient.
    Type: Grant
    Filed: October 30, 2012
    Date of Patent: July 24, 2018
    Assignee: SUPPREMOL GMBH
    Inventors: Peter Buckel, Peter Sondermann, Sascha Tillmanns, Ingrid Berger
  • Method for Treating or Preventing an Inflammatory Disease and/or an Autoimmune Disease
    Publication number: 20140120080
    Abstract: The present invention relates to a method for treating or preventing either one or both of an inflammatory disease and an autoimmune disease in a patient, wherein the method comprises providing a pharmaceutical composition containing a therapeutically effective amount of soluble Fc?R; administering said composition to a patient, followed by a safety period of several weeks, followed by a subsequent treatment cycle of at least two weekly administrations, wherein said therapeutically effective amount is effective to treat or prevent said disease in said patient. The present invention also provides a pharmaceutical composition in the form of a multiple-dosage-kit which contains sufficient amounts of administration doses of soluble Fc?R for effectively treating or preventing inflammatory diseases and/or autoimmune diseases in a patient.
    Type: Application
    Filed: October 30, 2012
    Publication date: May 1, 2014
    Applicant: SuppreMol GmbH
    Inventors: Peter Buckel, Peter Sondermann, Sascha Tillmanns, Ingrid Berger